<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Health Clinic Center of Fudan University and Chinese Center for" exact="Disease" post="Control and Prevention A severe respiratory disease emerged in"/>
 <result pre="and Chinese Center for Disease Control and Prevention A severe" exact="respiratory" post="disease emerged in the city of Wuhan, Hubei province,"/>
 <result pre="Chinese Center for Disease Control and Prevention A severe respiratory" exact="disease" post="emerged in the city of Wuhan, Hubei province, China,"/>
 <result pre="have been reported, including at least 564 deaths. Unfortunately, the" exact="disease" post="has spread globally. The etiologic agent, a novel coronavirus,"/>
 <result pre="to have stronger transmission capabilities among people. Compared to the" exact="primary" post="virus in humans, we still know less about whether,"/>
 <result pre="for their epidemics in humans. Control and prevention of the" exact="disease" post="is especially difficult in China and elsewhere if there"/>
 <result pre="there are infected individuals with no clinical signs. Sandbags for" exact="Disease" post="X MarionKoopmans Erasmus MC Whether it will be contained"/>
 <result pre="rapidly becoming the first true pandemic challenge that fits the" exact="disease" post="X category, listed to the WHOâ€™s priority list of"/>
 <result pre="with the SARS outbreak in terms of its origin, the" exact="disease" post="associated with infection, and the ability to spread are"/>
 <result pre="terms of higher transmissibility with efficient intra-familial spread and a" exact="lower" post="crude mortality. The key question is to find the"/>
 <result pre="that the nucleotide identity of SARS-CoV-2 genome, especially at the" exact="external" post="ectodomain of the receptor binding domain (RBD) of spike"/>
 <result pre="this virus more transmissible than other CoV that cause severe" exact="respiratory" post="disease (SARS-CoV and MERS-CoV)? Does this virus replicate more"/>
 <result pre="virus more transmissible than other CoV that cause severe respiratory" exact="disease" post="(SARS-CoV and MERS-CoV)? Does this virus replicate more readily"/>
 <result pre="and MERS-CoV)? Does this virus replicate more readily in the" exact="upper" post="airway than these other viruses and more similarly to"/>
 <result pre="these other viruses and more similarly to HCoV-NL63, which causes" exact="croup" post="and the common cold (but not pneumonia)? Is virus"/>
 <result pre="much transmission occurs when patients exhibit the earliest signs of" exact="disease" post="or even have subclinical disease? Second, is the virus"/>
 <result pre="virus? Bats may be the ultimate source, but is an" exact="intermediate" post="host involved? Finally, what are the unique molecular attributes"/>
 <result pre="emerge? Do the emerging viruses need to route through an" exact="intermediate" post="host prior to infecting humans? What accounts for the"/>
 <result pre="prior to infecting humans? What accounts for the spectrum of" exact="disease" post="outcomes when this happens, and what drives human-to-human spread?"/>
 <result pre="when this happens, and what drives human-to-human spread? Are there" exact="viral" post="and/or host genetic factors involved in disease outcome? From"/>
 <result pre="spread? Are there viral and/or host genetic factors involved in" exact="disease" post="outcome? From the public health perspective, the development of"/>
 <result pre="can be available are pressing. Previous work with pathogenic severe" exact="acute" post="respiratory syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS-CoV)"/>
 <result pre="be available are pressing. Previous work with pathogenic severe acute" exact="respiratory" post="syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS-CoV) coronaviruses"/>
 <result pre="available are pressing. Previous work with pathogenic severe acute respiratory" exact="syndrome" post="(SARS-CoV) and Middle East respiratory syndrome (MERS-CoV) coronaviruses provides"/>
 <result pre="with pathogenic severe acute respiratory syndrome (SARS-CoV) and Middle East" exact="respiratory" post="syndrome (MERS-CoV) coronaviruses provides insight and platforms that can"/>
 <result pre="pathogenic severe acute respiratory syndrome (SARS-CoV) and Middle East respiratory" exact="syndrome" post="(MERS-CoV) coronaviruses provides insight and platforms that can help"/>
 <result pre="the SARS-CoV-2 continues to spread and becomes embedded in the" exact="respiratory" post="virus disease landscape. Much remains to be learned about"/>
 <result pre="continues to spread and becomes embedded in the respiratory virus" exact="disease" post="landscape. Much remains to be learned about the SARS-CoV-2"/>
 <result pre="vaccine strategy. The Need for Diagnostics IsabellaEckerle Centre for Emerging" exact="Viral" post="Diseases, University Hospital Geneva and University of Geneva In"/>
 <result pre="almost endless possibilities for rapid pathogen identification, diagnosing a new" exact="viral" post="disease seems like an easy task. For SARS-CoV-2, the"/>
 <result pre="endless possibilities for rapid pathogen identification, diagnosing a new viral" exact="disease" post="seems like an easy task. For SARS-CoV-2, the first"/>
 <result pre="resource-limited areas such as sub-Saharan Africa, testing capacities are often" exact="limited" post="to reference laboratories, if existing at all. A realistic"/>
</results>
